CRSP CIK: 1674416

CRISPR Therapeutics AG

  • Switzerland
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
2.42
FY22:
1.85
FY23:
1.91
FY24:
1.94
FY25:
1.99
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.33
FY22:
0.39
FY23:
0.32
FY24:
0.30
FY25:
0.28
Total assets
Change from FY21 to FY25
billions USD
FY21:
2.75
FY22:
2.24
FY23:
2.23
FY24:
2.24
FY25:
2.27

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.12
FY22:
0.12
FY23:
0.11
FY24:
0.09
FY25:
0.15
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.23
FY22:
0.25
FY23:
0.24
FY24:
0.22
FY25:
0.19
(positive)
Change from FY21 to FY25
billions USD
FY21:
2.40
FY22:
1.88
FY23:
1.88
FY24:
1.93
FY25:
1.92
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
2.75
FY22:
2.24
FY23:
2.23
FY24:
2.24
FY25:
2.27

All amounts in billions USD Data source:SEC EDGAR